Reporting owner · CIK 0001754937

Moore Alison

Visual SEC Form 4 history across 2 companies, 4 transactions and 3 filings.

DIRArtiva Biotherapeutics, Inc.
Open-market mix
Filings3Form 4 records
Buying$00 purchases
Selling$5K1 sales
Net value−$5KBuys minus sells
Companies23 securities
Most recentSep 08, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Feb 251Feb 26Sep 26

Net value flow

Buys minus sells

Feb 25
$0
Feb 26
−$5K
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$5K
Median P/S size$5K
Direct4
Indirect0
Sep 08, 2026grant

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at CODEXIS, INC. on Feb 06, 2026 valued at $5,001.

Review SEC filing
Latest buy

No open-market insider purchase is available.

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ARTVMOORE ALISON
DIR
grant13.7k$0A0.0%09/0809/08
CDXSMOORE ALISON
PRES
sale3.82k-$500kS+120.9%02/0902/06
CDXSMOORE ALISON
CTO
grant161k$0A02/08/202502/05/2025
CDXSMOORE ALISON
CTO
grant26.8k$0A02/08/202502/05/2025

Moore Alison Insider Activity FAQ

SEC Form 4 context

Who is Moore Alison?

Moore Alison is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001754937.

Which companies has Moore Alison reported transactions for?

Artiva Biotherapeutics, Inc., CODEXIS, INC.

When was Moore Alison's latest insider buy?

No open-market insider purchase is available for this period.

When was Moore Alison's latest insider sale?

sale at CODEXIS, INC. on Feb 06, 2026 valued at $5,001.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.